The Access to Breast Cancer Diagnosis Act of 2025 eliminates cost-sharing for diagnostic and supplemental breast examinations.
The Access to Breast Cancer Diagnosis Act of 2025 amends the Public Health Service Act to prohibit group health plans and health insurance issuers from imposing cost-sharing requirements for diagnostic and supplemental breast examinations. This includes eliminating deductibles, coinsurance, copayments, and other out-of-pocket expenses for these examinations. The act also ensures that high deductible health plans remain eligible for health savings accounts despite this change. The amendments apply to plan years beginning on or after January 1, 2026.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.